Ranbaxy Inc., a research-based pharmaceutical company that manufactures generic product formulations, OTC and branded drug products, has been honored with the New Jersey Business Industry Association’s (NJBIA) Award for Excellence in Business Expansion and Economic Contribution to the State.
The NJBIA award acknowledges Ranbaxy’s commitment and contribution to the State, providing jobs for more than 700 New Jerseyans and with recent investments in its state-of-the-art manufacturing facilities in New Brunswick. NJBIA President Philip Kirschnerwill honor Ranbaxy and other recipients at an awards dinner on October 18, 2011 in Edison, NJ.
Ranbaxy entered the U.S. market in 1994 with a sales office in Raleigh, North Carolina. It acquired Ohm Laboratories of North Brunswick, NJ, its first U.S. manufacturing facility in 1995 and subsequently relocated its North American headquarters to Princeton, NJ. Ohm Laboratories produces quality and affordable generic prescription product formulations, as well as OTC medications.